Sagimet Biosciences grants 260,700 inducement stock options to new hires

Sagimet Biosciences set inducement equity awards tied to three new hires, totaling 260,700 stock options for Series A common shares.

The options were granted Aug. 17, 2026 with an exercise price set at the Series A closing price on Nasdaq that day.

The awards carry a 10-year term with four-year vesting: 25% after one year, with the remainder vesting monthly over the following 36 months.